Juniper Publishers journal of scientific and technical research

Juniper Publishers: Different Effects of Olive Leaf on Purine Metaboli... : Cancer Therapy & Oncology-Juniper Publishers Abstract Olive leaf (Olea europaea leaf) is a natural food source known to ha...

Juniper Publishers: Metal Weapons of “Warrior’ Burials” Found in the M... : Journal of Archaeology & Anthropology - Juniper Publishers Abstract Copper-based weapons including battleaxes, daggers, and spe...

Juniper Publishers: Simultaneous Estimation of Aliskiren and Amlodipin... : Journal of Organic & Medicinal Chemistry - Juniper Publishers Abstract Simple, sensitive and accurate UV-spectroscopic methods ...

Juniper Publishers: Recalling Incident of Own Accident for Suggesting ... : Orthopedics & Rheumatology-Juniper Publishers Opinion Quick access to emergency services for any reason is necessary that mi...

Juniper Publishers: Cytotoxicity Effects of LPR-1®, CCE100 and ONCOBLO... : Journal of Complementary Medicine & Alternative Healthcare - Juniper Publishers Abstract LPR-1 ® , CCE100 and ONCOBLOC ®  are L...

Juniper Publishers: On A Boundary Value Problem for A Singularly Pertu... : Journal of Biostatistics and Biometrics - Juniper Publishers Abstract In a semi-infinite strip we consider a boundary value pro...

Juniper Publishers: Prion theory: Induction of Prion Diseases by Nanop... : Journal of Neurology & Neurosurgery - Juniper Publishers Abstract Prion theory point to a mechanism of toxicity related to the ...

Journal of Trends in Technical and Scientific Research Keywords: Hypofractionated radiotherapy; Toxicities, Acceleration; Protocols; Sensitivity; Tissues Short Communication Hypofractionated radiotherapy for localized prostate cancer has recently been strongly recommended in evidence-based guidelines jointly published by ASTRO, ASCO and AUA [1]. While it has obvious advantages in cost and convenience, there remains a concern about associated acute and late toxicities: Two randomized controlled trials-HYPRO [2] and RTOG 0415 [3]-did identify a somewhat increased risk of late toxicity, and several, CHHiP [4], PROFIT [5], HYPRO and Fox Chase [6], all found increased risk of acute GI toxicity with hypofractionation. These concerns are greater when ultra-hypofractionation is used [1]. In order to reduce the acute and late toxicities, our group at Grand River Hospital, Kitchener, Ontario, back in 2006, started a Phase II trial [7] i...